A patient with a cochlear implant is at increased risk for pneumococcal meningitis. The CDC has recommended that a patient with a cochlear implant receive adequate pneumococcal vaccination before and after the procedure.
Types of vaccines available:
(1) pneumococcal conjugate vaccine, 7 valent (PCV7)
(2) pneumococcal polysaccharide vaccine, 23 valent (PPV23)
The conjugate vaccine is generally not recommended for anyone >= 60 months (5 years) of age.
Parameters:
(1) age in months
(2) number of doses of PCV7 received in primary series
(3) vaccination with additional dose PCV7
(4) vaccination with PPV23
Age in Months
Dosing Primary PCV7 Series
2 to 6
3 doses, 2 months apart
7 to 59
2 doses, 2+ months apart
An additional dose of PCV7 is given at 12-15 months of age if primary series started at < 12 months.
Age
Timing PPV23
< 24 months
complete PVC7; give when >= 24 months of age provided >= 8 weeks after last dose PVC7
24 - 59 months
give anytime provided >= 8 weeks after last dose PVC7
>= 60 months
To read more or access our algorithms and calculators, please log in or register.
Specialty: Infectious Diseases, Pharmacology, clinical, Pulmonology
ICD-10: ,
